Synaptogenix Inc (SNPX)

[InTheTrenches]

Agree here with Antii and Coach and Cyosol.

If we can reproduce the outstanding p<.02 results, showing that Alzheimer's patients improved (never been done before by any drug), then NTRP is in control of a drug that should be approved and should be one of the best-selling drugs of all time.

If we can get similar p-values from this confirmatory trial, NTRP stock should move well beyond $1B valuation within a few weeks/months of results.

Here's why: Not only will biotech funds ("specialists") need to own NTRP stock, but I believe "generalist" funds (those funds that can buy any stock, not just a sector) and hedge funds will want own stock in NTRP. This type of demand should see NTRP market cap easily get over $1B IMO. I see signs that the company is gearing up to get the word out if we are successful.

Yes, there's still risk, but I like the NTRP risk-reward proposition from here.